{Reference Type}: Meta-Analysis
{Title}: Reliability and feasibility of home-based dried blood spot in therapeutic drug monitoring: a systematic review and meta-analysis.
{Author}: Xiaoyong X;Xilin G;Guangfei W;Wei W;Xiaowen Z;Hong X;Huimin Z;Zhiping L;
{Journal}: Eur J Clin Pharmacol
{Volume}: 79
{Issue}: 2
{Year}: Feb 2023
{Factor}: 3.064
{DOI}: 10.1007/s00228-022-03417-9
{Abstract}: OBJECTIVE: Dried blood spot (DBS) is one of promising home sampling methods for therapeutic drug monitoring (TDM). However, the associated reliability and feasibility (including yield, adherence, and preference), which are criteria for the promotion of home-based DBS, remain unknown. This systematic review and meta-analysis aimed to evaluate the reliability and feasibility of TDM using DBS sampling.
METHODS: In this study, a combination of MeSH and free terms for (dried blood spot*[title/abstract])AND ("Drug Monitoring"[Mesh])AND(home OR venous)was surveyed using EMBASE, PubMed, Cochrane Library, and Web of Science upon gathering published. we registered this study protocol with the International Prospective Registry of Systematic Reviews (CRD42021247559).
RESULTS: Approximately half (35/75) of the evaluations reported good agreement between DBS and plasma, and the results for drugs with poor agreement may be improved using a haematocrit-based physiological equation. The yield and adherence to home-based DBS exceeded 87%, and questionnaire-based preference for DBS was 77%.
CONCLUSIONS: DBS may be a reliable and feasible home sampling method; however, it requires intricate design and evaluation before implementation.